Viewing Study NCT01199861


Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-01-15 @ 1:43 AM
Study NCT ID: NCT01199861
Status: COMPLETED
Last Update Posted: 2012-06-19
First Post: 2010-09-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsing multiple sclerosis View
None MS View
None Immune response View